Back to search

Geneform Technologies Limited

04549240

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

61 LONDON ROAD, MAIDSTONE, ME16 8TX
Incorporated 01/10/2002

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Mr Antti Tapani Koivula

director · Since 07/12/2018

CFO

FINNISH · FINLAND · Age 54

Mr Jukka Laukkonen

director · Since 01/04/2021

CHIEF TECHNICAL OFFICER (CTO)

FINNISH · FINLAND · Age 57

Persons with Significant Control

Former PSCs

Orion Pharma Uk Limited

Ceased 26/03/2018

CompanyRankvs 3426+ SIC 72190 peers
40

Financial strength67th percentile among SIC peers · 17/25
Employees20th percentile among SIC peers · 3/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength17/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

In forming our opinion on the financial statements we have considered the adequacy of the disclosure made in note 7 to the financial statements concerning the company's ability to continue as a going concern. Our opinion is not m od ified in respect of this matter. Senior Statutory Auditor: Julie Griggs FCA Statutory Auditor: Levicks Audit Services Limited Date of audit report: 26 March 2026

Key FinancialsYear ending 26/09/2025

Net Worth

£13k

Balance sheet strength

Cash

£3k

Cash in the bank

Net Current Assets

-£565

Working capital

Current Assets

Current Liabilities

0avg. employees
Prepared with CCH Software

EstimatesDerived

YearImplied Profit
2025+£0
2025+£0
2024+£760k

Derived from filed accounts. Not audited figures.